OPKO Health to Report Third Quarter 2019 Financial Results on November 5, 2019

NEXT STORY
NF Energy Saving Corporation Signs Strategic Partnership Agreements With Chengdu Gaoxin Hospital and Chongqing Guoyitang Hospital
PREV STORY
Myriad Genetics Announces Multiple Presentations at the 2019 American College of Rheumatology Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Casimersen (SRP-4045) for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45

author_avatar
NASDAQ Market News

Shire plc: Director/PDMR Shareholding

Director/PDMR Shareholding July 2, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of ...

author_avatar
NASDAQ Market News

Rain Therapeutics Announces Collaboration with Tempus for Genomic Analysis in Planned MDM2-Amplified Phase 2 Basket Trial of RAIN-32

author_avatar
NASDAQ Market News